IOL CHEMICALS & PHARM. | SAROJA PHARMA INDUSTRIES INDIA LTD. | IOL CHEMICALS & PHARM./ SAROJA PHARMA INDUSTRIES INDIA LTD. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.8 | - | - | View Chart |
P/BV | x | 1.6 | 3.3 | 47.0% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. SAROJA PHARMA INDUSTRIES INDIA LTD. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SAROJA PHARMA INDUSTRIES INDIA LTD. Mar-23 |
IOL CHEMICALS & PHARM./ SAROJA PHARMA INDUSTRIES INDIA LTD. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | NA | - | |
Low | Rs | 272 | NA | - | |
Sales per share (Unadj.) | Rs | 377.6 | 170.7 | 221.2% | |
Earnings per share (Unadj.) | Rs | 23.7 | 3.6 | 656.7% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 3.8 | 823.4% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 17.3 | 1,484.2% | |
Shares outstanding (eoy) | m | 58.71 | 2.94 | 1,996.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0 | - | |
Avg P/E ratio | x | 17.1 | 0 | - | |
P/CF ratio (eoy) | x | 12.8 | 0 | - | |
Price / Book Value ratio | x | 1.6 | 0 | - | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 8 | 20,315.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 502 | 4,417.2% | |
Other income | Rs m | 256 | 2 | 16,208.9% | |
Total revenues | Rs m | 22,427 | 504 | 4,454.2% | |
Gross profit | Rs m | 2,257 | 27 | 8,296.7% | |
Depreciation | Rs m | 462 | 1 | 68,895.5% | |
Interest | Rs m | 165 | 13 | 1,247.7% | |
Profit before tax | Rs m | 1,887 | 15 | 12,644.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 4 | 11,487.2% | |
Profit after tax | Rs m | 1,391 | 11 | 13,114.0% | |
Gross profit margin | % | 10.2 | 5.4 | 187.8% | |
Effective tax rate | % | 26.2 | 28.9 | 90.9% | |
Net profit margin | % | 6.3 | 2.1 | 297.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 161 | 5,985.8% | |
Current liabilities | Rs m | 5,025 | 134 | 3,742.1% | |
Net working cap to sales | % | 20.9 | 5.4 | 386.3% | |
Current ratio | x | 1.9 | 1.2 | 160.0% | |
Inventory Days | Days | 43 | 9 | 501.4% | |
Debtors Days | Days | 8 | 808 | 1.0% | |
Net fixed assets | Rs m | 11,017 | 52 | 21,224.0% | |
Share capital | Rs m | 587 | 29 | 1,999.7% | |
"Free" reserves | Rs m | 14,490 | 22 | 67,364.5% | |
Net worth | Rs m | 15,077 | 51 | 29,638.7% | |
Long term debt | Rs m | 0 | 28 | 0.0% | |
Total assets | Rs m | 20,684 | 213 | 9,692.5% | |
Interest coverage | x | 12.5 | 2.1 | 584.8% | |
Debt to equity ratio | x | 0 | 0.6 | 0.0% | |
Sales to assets ratio | x | 1.1 | 2.4 | 45.6% | |
Return on assets | % | 7.5 | 11.2 | 67.4% | |
Return on equity | % | 9.2 | 20.8 | 44.3% | |
Return on capital | % | 13.6 | 35.6 | 38.2% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 47 | 12,593.1% | |
Fx outflow | Rs m | 6,052 | 0 | 1,681,055.6% | |
Net fx | Rs m | -122 | 47 | -260.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 22 | 5,575.5% | |
From Investments | Rs m | -1,200 | -48 | 2,487.0% | |
From Financial Activity | Rs m | -41 | 27 | -150.5% | |
Net Cashflow | Rs m | -18 | 1 | -1,840.0% |
Indian Promoters | % | 48.2 | 73.0 | 66.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 27.0 | 192.0% | |
Shareholders | 130,003 | 506 | 25,692.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | SAROJA PHARMA INDUSTRIES INDIA LTD. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.80% | -1.74% | -0.23% |
1-Month | 6.38% | 1.56% | -0.32% |
1-Year | -1.61% | -38.10% | 53.43% |
3-Year CAGR | -12.80% | -14.77% | 14.82% |
5-Year CAGR | 17.57% | -9.15% | 19.74% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the SAROJA PHARMA INDUSTRIES INDIA LTD. share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of SAROJA PHARMA INDUSTRIES INDIA LTD. the stake stands at 73.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of SAROJA PHARMA INDUSTRIES INDIA LTD..
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
SAROJA PHARMA INDUSTRIES INDIA LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of SAROJA PHARMA INDUSTRIES INDIA LTD..
For a sector overview, read our pharmaceuticals sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.